Stockscreener 앱 받기
57.30
1.50%
0.80
전일 마감가:
$56.50
열려 있는:
$56.27
하루 거래량:
1.14M
Relative Volume:
0.43
시가총액:
$12.97B
수익:
$4.03B
순이익/손실:
$789.50M
주가수익비율:
17.21
EPS:
3.33
순현금흐름:
$1.15B
1주 성능:
+0.33%
1개월 성능:
-7.23%
6개월 성능:
-28.73%
1년 성능:
-23.45%
1일 변동 폭
$55.89
$57.44
1주일 범위
$55.89
$59.02
52주 변동 폭
$55.89
$84.67
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
HOLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
57.30 | 12.97B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
485.20 | 173.82B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
200.47 | 57.28B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.21 | 45.42B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.45 | 31.24B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.27 | 15.78B | 3.90B | 392.30M | 288.10M | 1.95 |
홀로직 Stock (HOLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-03 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | 다운그레이드 | Needham | Buy → Hold |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-12-10 | 재확인 | Needham | Buy |
| 2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-27 | 개시 | Stephens | Overweight |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-14 | 업그레이드 | Needham | Hold → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-05 | 재확인 | Needham | Buy |
| 2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 재확인 | Needham | Buy |
| 2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-01-31 | 재확인 | Needham | Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
Virology Testing Market Detailed In New Research Report 2025 | - openPR.com
Hyperpigmentation Treatment Devices Market Projected - openPR.com
Breast Lesion Localization Methods Market Detailed In New - openPR.com
Biopsy Devices Market Set to Witness Significant Growth - openPR.com
Mizuho Securities Cuts Hologic Price Target to $75 From $83, Maintains Outperform Rating - MarketScreener
Sentinel Node Biopsy Market Growth in 2025 Driven by Precision - openPR.com
Sentinel Node Biopsy Market to Witness Remarkable Growth with - openPR.com
BofA Reduces Price Target for Hologic (HOLX) Amid Industry Headw - GuruFocus
Why Hologic (HOLX) Outpaced the Stock Market Today - Yahoo Finance
What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate? - Yahoo Finance
Fluoroscopy Devices Market Is Booming Worldwide with Positive - openPR.com
Breast Cancer Brachytherapy Market Future Business - openPR.com
Immunoassay Analyzers Market Size to Hit USD 10.16 Billion by 2032 | SNS Insider - GlobeNewswire Inc.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
X-ray Machine Manufacturing Market Generated Opportunities, - openPR.com
Hologic stock hits 52-week low at $57.36 amid market shifts - Investing.com India
Hologic stock hits 52-week low at $57.36 amid market shifts By Investing.com - Investing.com South Africa
Non-Invasive Cancer Diagnostics Market to Witness Massive - openPR.com
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance
Analyzing Hologic, Inc. v. Stepp: Key takeaways - Eversheds Sutherland
Histology And Cytology Market Is Booming Worldwide 2025-2032 | - openPR.com
Digital X-ray Devices Market to Witness Massive Growth by 2032 | - openPR.com
Virology Testing Market to Witness Remarkable Growth with - openPR.com
RBC Cuts Price Target on Hologic to $75 From $83, Keeps Sector Perform Rating - MarketScreener
Hologic (HOLX) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Hologic adds Solventum CFO McMillan to its board - MassDevice
Hologic Brings In New Leadership: A Signal To Stay Put With The Stock? - Barchart.com
Hologic Brings in New Leadership: A Signal to Stay Put With the Stock? - Yahoo Finance
Hologic Onboards Wayde McMillan to its Board of Directors - World Business Outlook
Wayde McMillan Elected to Hologic Board of Directors - citybiz
Hologic adds Wayde McMillan to its Board of Directors By Investing.com - Investing.com South Africa
Hologic Expands Board with New Director Appointment - TipRanks
Hologic adds Wayde McMillan to its Board of Directors - Investing.com
Wayde Mcmillan Elected To Hologic Board Of Directors - MarketScreener
Wayde McMillan Elected to Hologic Board of Directors – Company Announcement - Financial Times
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025 - MarketScreener
Biopsy Devices Market Projected To Witness Massive Growth, - openPR.com
Groupama Asset Managment Acquires 21,037 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Mark Your Calendar: Hologic Sets Critical Q2 Earnings Report Date - Stock Titan
Evercore ISI Adjusts Price Target on Hologic to $65 From $73, Maintains In Line Rating - MarketScreener
Mitsubishi UFJ Trust & Banking Corp Has $13.99 Million Stock Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
RBC Adjusts Price Target on Hologic to $83 From $85, Maintains Sector Perform Rating - MarketScreener
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
홀로직 주식 (HOLX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mitchell Essex D | Chief Operating Officer |
Dec 04 '24 |
Sale |
76.34 |
24,856 |
1,897,482 |
27,957 |
0.27%
0.61%
자본화:
|
볼륨(24시간):